Limbic Resources Inc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 775 E Falmouth Hwy, #275, East Falmouth, MA 02536 Phone: 508-648-6491 |
Cape Senior Services Llc Social Worker Medicare: Not Enrolled in Medicare Practice Location: 178 E Falmouth Hwy, East Falmouth, MA 02536 Phone: 617-515-3070 |
Enhanced Mental Health Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 51 Galleon Dr, East Falmouth, MA 02536 Phone: 617-877-0259 Fax: 844-231-9755 |
Calm Shores Counseling Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 70 E Falmouth Hwy Ste 6a, East Falmouth, MA 02536 Phone: 860-796-7090 |
News Archive
Researchers at Cold Spring Harbor Laboratory (CSHL) have solved an important piece of one of neuroscience's outstanding puzzles: how progenitor cells in the developing mammalian brain reproduce themselves while also giving birth to neurons that will populate the emerging cerebral cortex, the seat of cognition and executive function in the mature brain.
A research team led by Nancy Speck, PhD, professor of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, has discovered a molecular marker for the immediate precursors of hematopoietic (blood) stem cells (HSCs) in the developing embryo, which provides much-needed insights for making these cells from engineered precursors.
The giant home improvement chain said it will send almost 20,000 part-time employees to the health law's online marketplaces for insurance. Meanwhile, the Associated Press reports that small businesses are racing to renew their health policies before year's end to avoid having to comply with the health law's requirements, which take effect Jan. 1.
The Medical House, orthopaedic devices and drug delivery company and BioPartners GmbH the global biopharmaceuticals company are pleased to announce a 10 year agreement for license and supply of The Medical House's GH1 reusable, spring-powered, needle-free delivery system for the delivery of BioPartners' human growth hormone product, Valtropin.
Exelixis, Inc. announced that today it granted a nonstatutory stock option to purchase 32,500 shares of Exelixis common stock and restricted stock units representing an aggregate of 37,750 shares of Exelixis common stock to nine new employees.
› Verified 3 days ago